Health-related quality of life and nail disorders

Acta Dermato-Venereologica

Volumn 87, Issue 3, 2007, Pages 255-259

  Tabolli, Stefano ^a   Alessandroni, Livia ^a   Gaido, Jeanette ^a   Sampogna, Francesca ^a   Di Pietro, Cristina ^a   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Dermatology; Life quality; Nail disorder onychomycosis; Outcome research

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DISEASE DURATION; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL DISEASE; ONCHOCERCIASIS; PAIN; PRIORITY JOURNAL; PSYCHOTRAUMA; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SKIN DISEASE; SOCIAL INTERACTION; SYMPTOM; AGE; HUMAN RELATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; EMOTIONS; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; NAIL DISEASES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34447522225     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0224     Document Type: Article

References (25)

1. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001; 322: 1297-1300.
2. Lohr KN. Advances in health status assessment. Overview of the conference. Med Care 1989; 27: S1-11.
3. Lohr KN. Applications of health status assessment measures in clinical practice. Overview of the third conference on advances in health status assessment. Med Care 1992; 30: MS1-14.
4. Bowling A, editor. Measuring disease. Buckingam: Open University Press, 1995.
5. Rosser RM. A history of development of health indices. In Smith GT, editor. Measuring the social benefits of medicine. London: Office of Health Economics, 1985.
6. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
7. Abeni D, Picardi A, Puddu P, Pasquini P, Chren MM. Construction and validation of the Italian version of Skindex-29, a new instrument to measure quality of life in dermatology [in Italian, abstract in English]. G Ital Dermatol Venereol 2001; 136: 73-76.
8. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2242 dermatological outpatients. Dermatology 2002; 204: 43-49.
9. Piccinelli M, Bisoffi G, Bon MG, Cunico L, Tansella M. Validity and test-retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods. Compr Psychiatry 1993; 34: 198-205.
10. Picardi A, Abeni D, Pasquini P. Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol 2001; 15: 410-417.
11. Picardi A, Abeni D, Mazzotti E, Fassone G, Lega I, Ramieri L, et al. Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire (GHQ-12). J Psychosom Res 2004; 57: 219-223.
12. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
13. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-1036.
14. Sampogna F, Picardi A, Chren MM, Melchi CF, Pasquini P, Abeni D. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004; 66: 620-624.
15. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
16. Shear RK, Drake LA. Onychomycosis: a significant disease. In: Proceedings of the 2nd International Symposium on Onychomycosis, Florence, Italy, Sept 28-29 1995. Macclesfield: Gariner-Calwell Communication Ltd, 1996.
17. Shear NH, Gupta AK. Terbinafine for the treatment of pedal onychomycosis: a foot closer to the promised land of cured nails? Arch Dermatol 1995; 131: 937-942.
18. Lubeck DP, Gause D, Schein JR, Prebil LE, Potter LP. A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual life Res 1999; 8: 121-129.
19. Drake LA, Patrick DL, Fleckman P, André J, Baran R, Haneke E, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999; 41: 189-196.
20. Turner RR, Testa MA. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res 2000; 9: 39-53
21. Whittam LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exp Dermatol 1997; 22: 87-89.
22. Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997; 36: 754-756.
23. Shaw JW, Joish VN, Coons SJ. Onychomycosis: health - related quality of life considerations. Pharmacoeconomics 2002; 20: 23-36.
24. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-54.
25. Picardi A, Abeni D, Renzi C, Braga M, Puddu P, Pasquini P. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol 2001; 81: 410-414.